Adtalem Global Education Inc. (NYSE:CVSA - Get Free Report) has received an average rating of "Hold" from the five brokerages that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $151.67.
A number of equities research analysts have recently weighed in on the company. BMO Capital Markets cut their price target on Adtalem Global Education from $148.00 to $145.00 and set an "outperform" rating for the company in a research note on Monday, October 5th. Weiss Ratings raised Adtalem Global Education from a "hold (c)" rating to a "hold (c+)" rating in a research note on Wednesday, October 21st. Wall Street Zen upgraded Adtalem Global Education from a "hold" rating to a "buy" rating in a report on Sunday, September 27th. Finally, Truist Financial downgraded Adtalem Global Education from a "buy" rating to a "hold" rating and set a $140.00 price objective on the stock. in a report on Thursday, September 3rd.
Check Out Our Latest Research Report on Adtalem Global Education
Insider Buying and Selling at Adtalem Global Education
In other news, CAO Manjunath Gangadharan sold 1,802 shares of the stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $137.18, for a total transaction of $247,198.36. Following the transaction, the chief accounting officer owned 5,083 shares in the company, valued at $697,285.94. This represents a 26.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen Beard sold 4,667 shares of the stock in a transaction on Friday, October 9th. The stock was sold at an average price of $130.77, for a total transaction of $610,303.59. Following the transaction, the chief executive officer owned 469,158 shares in the company, valued at approximately $61,351,791.66. This trade represents a 0.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 20,365 shares of company stock valued at $2,704,088. 2.70% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Adtalem Global Education
An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new stake in shares of Adtalem Global Education Inc. (NYSE:CVSA - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 11,622 shares of the company's stock, valued at approximately $1,449,000. Hedge funds and other institutional investors own 98.84% of the company's stock.
Adtalem Global Education Trading Up 1.8%
Shares of NYSE:CVSA opened at $128.77 on Friday. The firm has a fifty day moving average of $128.06 and a two-hundred day moving average of $122.06. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.45. Adtalem Global Education has a 12-month low of $86.97 and a 12-month high of $145.43. The firm has a market capitalization of $4.36 billion, a P/E ratio of 18.29, a price-to-earnings-growth ratio of 0.94 and a beta of 0.65.
Adtalem Global Education (NYSE:CVSA - Get Free Report) last posted its quarterly earnings results on Thursday, October 29th. The company reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.90 by $0.29. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The business had revenue of $511.53 million for the quarter. On average, equities analysts expect that Adtalem Global Education will post 9.00 EPS for the current fiscal year.
About Adtalem Global Education
(
Get Free Report)
Adtalem Global Education, Inc is an education services company that provides healthcare and professional education through institutions serving students in the United States and internationally. The company focuses on preparing students for careers in healthcare, including nursing, medicine, veterinary medicine and other health-related fields.
Its portfolio has included Chamberlain University, Walden University, the American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Adtalem Global Education, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adtalem Global Education wasn't on the list.
While Adtalem Global Education currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.